Crossmark

Correction: Donanemab: First Approval

Crossref DOI link: https://doi.org/10.1007/s40265-024-02103-7

Published Online: 2024-10-15

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kang, Connie
License Information

Text and Data Mining valid from 2024-10-01

Version of Record valid from 2024-10-01
More Information

Article History

Accepted: 27 September 2024

First Online: 15 October 2024

Free to read: This content has been made available to all.